Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;6(9):1499-503.
doi: 10.7860/JCDR/2012/4759.2543.

A Prospective, Open-label Study to Compare the Efficacy and the Safety of Topical Loteprednol Etabonate and Topical Flurbiprofen Sodium in Patients with Post-Operative Inflammation after Cataract Extraction

Sheshidhar G Bannale  1 , H P Pundarikaksha, H N Sowbhagya
Affiliations

A Prospective, Open-label Study to Compare the Efficacy and the Safety of Topical Loteprednol Etabonate and Topical Flurbiprofen Sodium in Patients with Post-Operative Inflammation after Cataract Extraction

Sheshidhar G Bannale et al. J Clin Diagn Res. 2012 Nov.

Abstract

Purpose: To study the effect of the topical Non-Steroidal Anti Inflammatory Drug (NSAID), Flurbiprofen 0.03%, as an alternative to the topical steroids for the postoperative control of inflammation in cataract surgeries.

Methods: The effect of the topical NSAID, flurbiprofen sodium 0.03%, was studied and compared with that of the topical steroid - Loteprednol etabonate 0.5% suspension (as eye drops) in a prospective, open labelled study. Both the groups (20 patients each) were similar in the baseline parameters. The postoperative inflammatory response following the standard, small incision, extra capsular cataract extraction was assessed in both the groups for 28 post-operative days. The parameters which were considered for the study were conjunctival hyperaemia, ciliary congestion, corneal oedema, cells in the anterior chamber, aqueous flare and ocular pain. The severity of the postoperative inflammatory responses for both the drugs was graded on the post-operative days 1, 7, 14, 21 and 28 and it was statistically analyzed.

Results: The 2 groups did not differ statistically in the effect of the treatment for any of the variables, which included aqueous cells, flare, ciliary congestion and conjunctival congestion (p< 0.001). Both the drugs were well tolerated and no severe adverse Drug Reactions (ADRs) were caused by the topical NSAID and the topical steroid.

Conclusion: The topical NSAID, Flurbiprofen, is as effective as the topical corticosteroid, Loteprednol and it can be used as an alternative in the routine postoperative treatment following uncomplicated cataract surgeries.

Keywords: Anti-inflammatory drugs; Cataract extraction; Loteprednol; Post-operative inflammation.

PubMed Disclaimer

Figures

[Table/Fig-2]
[Table/Fig-2]
Conjunctival Hyperaemia mean-score comparison
[Table/Fig-3]
[Table/Fig-3]
Side effect profile-comparison
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Harry J, Misson G. Clinical Ophthalmic Pathology. New Delhi: Butterworth Heineman; 2001. Immunity, Inflammation and Infection; pp. 30–113.
    1. Pavesion CE, Decory HH. The treatment of the ocular inflammatory conditions with Loteprednol etabonate. Brit J Ophthalmol. 2008;92:455–59. - PubMed
    1. Hayat AK, Abandan KA. Topical diclofenac versus dexamethasone after strabismus surgeries- A blind randomized clinical trial on the anti-inflammatory effect and the ocular hypertensive response. Indian J Ophthalmol. 2007;55:271–75. - PubMed
    1. Manjoo SR, Suneetha N, Reji KT, Batt RR. Topical diclofenac sodium for the treatment of postoperative inflammation. Drugs. 2007;67(9):1291–308. - PubMed
    1. Sihota R, Tondon R. Parson's Diseases of the Eye. 20th ed. Noida (India): Elsevier; 2008. Diseases of the Conjunctiva; pp. 155–80.

LinkOut - more resources